# Human Placenta-derived 3D Mesenchymal Stem Cells(Guojianqingke)

> **NCT07635758** · PHASE1,PHASE2 · RECRUITING · sponsor: **Chinese PLA General Hospital** · enrollment: 24 (estimated)

## Conditions studied

- Acute Ischemic Stroke

## Interventions

- **BIOLOGICAL:** Human Placenta-derived 3D Mesenchymal Stem Cells (Guojiangqingke)

## Key facts

- **NCT ID:** NCT07635758
- **Lead sponsor:** Chinese PLA General Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-06-01
- **Primary completion:** 2027-12-30
- **Final completion:** 2028-12
- **Target enrollment:** 24 (ESTIMATED)
- **Last updated:** 2026-06-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07635758

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07635758, "Human Placenta-derived 3D Mesenchymal Stem Cells(Guojianqingke)". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07635758. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*